Osaic Holdings’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,187
Closed -$103 7608
2023
Q3
$103 Hold
1,187
﹤0.01% 7228
2023
Q2
$665 Hold
1,187
﹤0.01% 6985
2023
Q1
$1.35K Hold
1,187
﹤0.01% 6862
2022
Q4
$1K Hold
1,187
﹤0.01% 7033
2022
Q3
$2K Hold
1,187
﹤0.01% 6884
2022
Q2
$2K Hold
1,187
﹤0.01% 6974
2022
Q1
$2K Hold
1,187
﹤0.01% 6939
2021
Q4
$1K Sell
1,187
-500
-30% -$811 ﹤0.01% 7297
2021
Q3
$5K Hold
1,687
﹤0.01% 6572
2021
Q2
$6K Hold
1,687
﹤0.01% 6323
2021
Q1
$6K Hold
1,687
﹤0.01% 6104
2020
Q4
$7K Hold
1,687
﹤0.01% 5682
2020
Q3
$9K Buy
+1,687
New +$9.72K ﹤0.01% 5353

Other funds holding RVLP

Osaic Holdings's RVLP Position: Q4 2023 in Review

Osaic Holdings sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 1,187 shares — an estimated $103 sold.

Osaic Holdings first reported a position in RVLP in Q3 2020 and held it in 13 quarters. The position peaked at $9K in Q3 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Osaic Holdings reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 1,187 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $103.
  • Osaic Holdings first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • Osaic Holdings's RVL Pharmaceuticals plc Ordinary Shares position peaked at $9K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.